Hybridoma lines that secrete human monoclonal antibodies with high binding specificity and biological activity, particularly neutralizing activity against granulocyte-macrophage colony stimulating factor, and methods of generating the hybridoma lines are provided. Target antigens and epitopes are also provided. The antibodies may be used in therapeutic methods, for example in the treatment of cancer, infectious disease, or autoimmune disease.

 
Web www.patentalert.com

< Diagnostic markers, especially for in vivo imaging and assays and methods of use thereof

< Fusion antibodies that cross the blood-brain barrier in both directions

> Long lasting fusion peptide inhibitors for HIV infection

> Nucleic acid probes and methods for detecting clinically important fungal pathogens

~ 00617